Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

por Zhu, Yuan Xiao, Shi, Chang-Xin, Bruins, Laura A., Wang, Xuewei, Riggs, Daniel L., Porter, Brooke, Ahmann, Jonathan M., de Campos, Cecilia Bonolo, Braggio, Esteban, Bergsagel, P. Leif, Stewart, A. Keith
Publicado 2019

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism

por Gonzalez, Mayra A., Olivas, Idaly M., Bencomo‐Alvarez, Alfonso E., Rubio, Andres J., Barreto‐Vargas, Christian, Lopez, Jose L., Dang, Sara K., Solecki, Jonathan P., McCall, Emily, Astudillo, Gonzalo, Velazquez, Vanessa V., Schenkel, Katherine, Reffell, Kelaiah, Perkins, Mariah, Nguyen, Nhu, Apaflo, Jehu N., Alvidrez, Efren, Young, James E., Lara, Joshua J., Yan, Dongqing, Senina, Anna, Ahmann, Jonathan, Varley, Katherine E., Mason, Clinton C., Eide, Christopher A., Druker, Brian J., Nurunnabi, Md, Padilla, Osvaldo, Bajpeyi, Sudip, Eiring, Anna M.
Publicado 2022